AN2 Therapeutics Cash Flow Statement (2021-2026) | ANTX

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-4.98M-6.91M-7.57M-7.66M-10.11M-11.30M-11.85M-16.04M-16.60M-18.18M-18.82M-16.62M-14.44M-12.75M-7.52M-10.65M-6.46M-9.35M-8.71M-10.03M
Share-based Compensation (Quarter)
0.18M0.35M0.43M0.45M1.24M1.23M1.47M2.00M1.94M2.17M2.23M2.38M2.27M1.90M1.78M2.05M2.00M0.80M1.40M1.46M
Gains from Sales and Divestitures (Quarter)
0.01M0.03M0.04M0.12M0.15M0.25M0.30M0.28M
Gains from Investment Securities (Quarter)
1.59M0.07M2.47M2.47M2.80M0.92M1.09M0.05M3.93M0.93M0.03M1.47M4.89M5.74M0.15M0.39M5.47M6.44M
Non-cash Items (Quarter)
5.48M5.70M0.63M13.20M5.79M1.17M4.78M18.90M37.85M2.07M18.00M2.77M0.33M7.60M0.13M3.70M0.17M4.23M
Cash from Operations (Quarter)
-5.26M-4.69M-8.99M-6.74M-9.60M-9.49M-7.64M-11.60M-12.82M-11.78M-17.09M-17.59M-14.38M-12.02M-5.26M-10.62M-7.58M-6.40M-5.23M-12.07M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.02M-0.02M-0.00M0.07M0.24M0.38M0.43M0.46M0.65M1.31M1.09M0.89M0.73M0.57M0.44M0.30M0.21M0.12M0.08M
Change in Working Capital
Change in Account Payables (Quarter)
0.27M0.71M-0.95M1.55M0.44M-0.17M0.68M1.42M-0.41M1.65M-2.11M-0.24M-0.55M-0.17M1.61M-0.24M-0.96M0.11M0.80M-0.41M
Change in Accured Expenses (Quarter)
0.19M0.26M0.35M0.06M-0.27M0.90M0.56M1.36M2.25M-2.63M-0.31M-3.02M0.84M0.42M-0.47M-0.41M-1.09M0.89M-1.79M-0.28M
Investing Activities
Change in Acquisitions & Divestments (Quarter)
22.25M14.97M13.50M20.09M23.50M24.90M21.00M22.75M20.25M26.29M29.05M28.50M17.50M31.50M17.50M10.00M15.50M10.99M
Cash from Investing Activities (Quarter)
-6.99M6.25M13.98M-39.49M-2.32M6.05M10.89M7.88M-62.46M0.42M26.29M16.46M18.72M-6.88M9.19M5.83M6.11M7.17M8.29M
Financing Activities
Other financing activities (Quarter)
0.97M
Change in Capital Stock
Shares Issued (Quarter)
0.00M63.20M7.18M-0.01M0.20M19.00M0.12M0.10M0.04M0.05M0.02M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
-0.24M-0.97M63.19M7.18M-0.01M0.20M19.05M66.07M-0.32M0.35M0.02M0.07M0.05M37.33M
Change in Cash (Quarter)
-54.54M-11.92M-3.72M70.42M-41.90M-11.81M-1.58M-0.51M14.10M-8.20M-16.97M9.05M2.08M6.74M-12.15M-1.37M-1.76M-0.22M1.94M33.55M
Free Cash Flow (Quarter)
-5.26M-4.69M-8.99M-6.74M-9.60M-9.49M-7.64M-11.60M-12.82M-11.78M-17.09M-17.59M-14.38M-12.02M-5.26M-10.62M-7.58M-6.40M-5.23M-12.07M
Net Cash Flow (Quarter)
-5.26M-11.92M-3.72M70.42M-41.90M-11.81M-1.58M-0.51M14.10M-8.18M-16.99M9.05M2.08M6.72M-12.14M-1.37M-1.74M-0.24M1.94M33.55M